The evolution of AI in drug discovery: learning from history’s mistakes (Part 2)
In this second part of a two-part series, we continue…
In this second part of a two-part series, we continue Sujeegar Jeevanandam’s exploration of the future of AI in drug discovery. We share his vision for transformative AI applications, such as simulating human pharmacokinetics and pharmacodynamics, and offer strategic recommendations for biotechs looking to adopt AI.